Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease - an Observational Study

NCT07457463 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT07457463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07457463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease - an Observational Study
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Not applicable
Overall status
Recruiting
Start date
October 7, 2025
Completion date
August 31, 2027
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung fibrosis interstitial